Brazil's consumer price inflation eased for the tenth straight month in April to reach its lowest level in two-and-a-half years, figures from the Brazilian Institute of Geography and Statistics, or IBGE, showed on Friday.
/PRNewswire/ Today, the U.S. Food and Drug Administration is announcing the supplemental approval of Rexulti (brexpiprazole) oral tablets for the treatment.
The U.S. Food and Drug Administration has granted supplemental approval of Rexulti oral tablets for the treatment of agitation associated with dementia due to Alzheimer’s disease.
THURSDAY, May 11, 2023 (HealthDay News) A medication to treat agitation in Alzheimer s patients now has approval from the U.S. Food and Drug Administration.